Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Single-cell profiling reveals pathogenic role and differentiation trajectory of granzyme K+CD8+ T cells in primary Sjögren’s syndrome
Ting Xu, … , Zhe-Xiong Lian, Cai-Yue Gao
Ting Xu, … , Zhe-Xiong Lian, Cai-Yue Gao
Published March 7, 2023
Citation Information: JCI Insight. 2023;8(8):e167490. https://doi.org/10.1172/jci.insight.167490.
View: Text | PDF
Research Article Immunology

Single-cell profiling reveals pathogenic role and differentiation trajectory of granzyme K+CD8+ T cells in primary Sjögren’s syndrome

  • Text
  • PDF
Abstract

Primary Sjögren’s syndrome (pSS) is a systemic autoimmune inflammatory disease mainly defined by T cell–dominated destruction of exocrine glands. Currently, CD8+ T cells are thought to be involved in the pathogenesis of pSS. However, the single-cell immune profiling of pSS and molecular signatures of pathogenic CD8+ T cells have not been well elucidated. Our multiomics investigation showed that both T cells and B cells, especially CD8+ T cells, were undergoing significant clonal expansion in pSS patients. TCR clonality analysis revealed that peripheral blood granzyme K+ (GZMK+) CXCR6+CD8+ T cells had higher a proportion of clones shared with CD69+CD103–CD8+ tissue-resident memory T (Trm) cells in labial glands in pSS. CD69+CD103–CD8+ Trm cells featured by high expression of GZMK were more active and cytotoxic in pSS compared with their CD103+ counterparts. Peripheral blood GZMK+CXCR6+CD8+ T cells with higher CD122 expression were increased and harbored a gene signature similar to Trm cells in pSS. Consistently, IL-15 was significantly elevated in pSS plasma and showed the capacity to promote differentiation of CD8+ T cells into GZMK+CXCR6+CD8+ T cells in a STAT5-dependent manner. In summary, we depicted the immune profile of pSS and further conducted comprehensive bioinformatics analysis and in vitro experimental investigations to characterize the pathogenic role and differentiation trajectory of CD8+ Trm cells in pSS.

Authors

Ting Xu, Hao-Xian Zhu, Xing You, Jin-Fen Ma, Xin Li, Pan-Yue Luo, Yang Li, Zhe-Xiong Lian, Cai-Yue Gao

×

Figure 5

GZMK+CXCR6+CD8+ T cells are Trm precursors.

Options: View larger image (or click on image) Download as PowerPoint
GZMK+CXCR6+CD8+ T cells are Trm precursors.
(A) UMAP plot shows cluster ...
(A) UMAP plot shows cluster distribution of CD8+ T cells in LGs and PBMCs from pSS patients. (B) UMAP plot shows the tissue distribution of CD8+ T cells. (C) Trm score of the PBMC CD8+ T cell cluster and LG Trm cells. LG_CD8TRM includes CD103+CD8+ Trm and CD103–CD8+ Trm cells. (D) Proportion of clone types shared with CD103+CD8+ Trm or CD103–CD8+ Trm cells. (E) The distribution of clones shared with CD103–CD8+ Trm cells in GZMK_CD8TM. (F) Monocle3-derived pseudotime and trajectory line of CD8+ T cells on UMAP plot. (G) Volcano plot shows the differentially expressed genes in cells with shared clones of GZMK_CD8TM. (H) Frequency of CXCR6+GZMK+CD8+ T cells in PBMC CD8+ T cells from pSS patients (n = 22) and HCs (n = 9). Blue bar represents cells from HCs and red pSS patients. (I) The geometric mean fluorescence intensity of HLA-DR in CXCR6+GZMK+CD8+ T cells, CXCR6–GZMK+CD8+ T cells, GZMB+CD8+ T cells, and GZMB–GZMK–CD8+ T cells in PBMCs from pSS patients (n = 15). Red dots represent GZMK+CXCR6+CD8+ T cells and blue GZMB+CD8+ T cells. (J) Representative flow cytometry plots show the EOMES expression of CXCR6+GZMK+CD8+ T cells and GZMK+CD103–CD8+ Trm cells. The experiment was performed 3 times. Data are presented as mean ± SD. **P < 0.01; ***P < 0.001 by 2-tailed, unpaired Student’s t test (H) or 1-way ANOVA with Dunnett’s multiple-comparison test (I).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts